Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5ADC

Structure of rat neuronal nitric oxide synthase heme domain in complex with 7-(((5-((Methylamino)methyl)pyridin-3-yl)oxy)methyl) quinolin-2-amine

5ADC の概要
エントリーDOI10.2210/pdb5adc/pdb
関連するPDBエントリー5AD4 5AD5 5AD6 5AD7 5AD8 5AD9 5ADA 5ADB 5ADD 5ADE 5ADF 5ADG 5ADI 5ADJ 5ADK 5ADL 5ADM 5ADN
分子名称NITRIC OXIDE SYNTHASE, BRAIN, PROTOPORPHYRIN IX CONTAINING FE, 5,6,7,8-TETRAHYDROBIOPTERIN, ... (7 entities in total)
機能のキーワードoxidoreductase, nitric oxide synthase, inhibitor complex
由来する生物種RATTUS NORVEGICUS (NORWAY RAT)
細胞内の位置Cell membrane, sarcolemma ; Peripheral membrane protein : P29476
タンパク質・核酸の鎖数2
化学式量合計100108.69
構造登録者
Li, H.,Poulos, T.L. (登録日: 2015-08-20, 公開日: 2015-10-28, 最終更新日: 2024-05-08)
主引用文献Cinelli, M.A.,Li, H.,Pensa, A.V.,Kang, S.,Roman, L.J.,Martasek, P.,Poulos, T.L.,Silverman, R.B.
Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
J.Med.Chem., 58:8694-, 2015
Cited by
PubMed Abstract: Excess nitric oxide (NO) produced by neuronal nitric oxide synthase (nNOS) is implicated in neurodegenerative disorders. As a result, inhibition of nNOS and reduction of NO levels is desirable therapeutically, but many nNOS inhibitors are poorly bioavailable. Promising members of our previously reported 2-aminoquinoline class of nNOS inhibitors, although orally bioavailable and brain-penetrant, suffer from unfavorable off-target binding to other CNS receptors, and they resemble known promiscuous binders. Rearranged phenyl ether- and aniline-linked 2-aminoquinoline derivatives were therefore designed to (a) disrupt the promiscuous binding pharmacophore and diminish off-target interactions and (b) preserve potency, isoform selectivity, and cell permeability. A series of these compounds was synthesized and tested against purified nNOS, endothelial NOS (eNOS), and inducible NOS (iNOS) enzymes. One compound, 20, displayed high potency, selectivity, and good human nNOS inhibition, and retained some permeability in a Caco-2 assay. Most promisingly, CNS receptor counterscreening revealed that this rearranged scaffold significantly reduces off-target binding.
PubMed: 26469213
DOI: 10.1021/ACS.JMEDCHEM.5B01330
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.1 Å)
構造検証レポート
Validation report summary of 5adc
検証レポート(詳細版)ダウンロードをダウンロード

231029

件を2025-02-05に公開中

PDB statisticsPDBj update infoContact PDBjnumon